BODY MASS INDEX ACCORDING TO INSULIN AND ORAL HYPOGLYCEMIC DRUG USAGE IN PATIENTS WITH TYPE 2 DIABETES.

  • Teaching assistant and Senior Registrar in internal medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Teaching assistant, Senior Registrar in internal medicine and Endocrine Fellow, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Medical Resident, King AbdulAziz University Hospital, Jeddah, Saudi Arabia.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective: Obesity is highly prevalent in Saudi Arabia, resulting in an increase in the risk diabetes mellitus. A sedentary lifestyle with limited participation in outdoor activities could exacerbate the effects of obesity on diabetes mellitus. Moreover, although insulin replacement therapy is the most effective treatment for hyperglycemia in type 1 and advanced type 2 diabetes, it is associated with weight gain. Therefore, the aim of our study was to evaluate body mass index patterns, according to insulin and oral hypoglycemic drug (OHG) usage, in patients with type 2 diabetes in the western region of Saudi Arabia, who have a relatively sedentary lifestyle. Methods: In this prospective study, 96 adults aged 40?90 years with type 2 diabetes were selected from among patients visiting the outpatient department of King Abdul Aziz University Hospital between February 1, 2017 and February 28, 2017. A majority of the participants were female (68%). The body mass index of all study participants was measured and compared according to the presence of absence of insulin and OHG usage. Results: Among the study participants, 75% and 33.3% were taking OHG and insulin, respectively. Evaluation of the patient BMI patterns revealed that patients OHG use had a significant negative correlation with increased BMI (p = 0.015). In addition, no significant difference in BMI was found between diabetic patients who were taking insulin and those not taking insulin (p = 0.093). Conclusion: Our findings regarding the high prevalence of overweight or obesity among patients with diabetes suggests increased surveillance of weight in this patient population. Moreover, in diabetic patient in the western region of Saudi Arabia, insulin use plays a role in increasing weight, in addition to the limited outdoor activities and an unhealthy diet. Screening diabetes treatment outcomes and promoting awareness of the risk of obesity and diabetes and the effect of good lifestyle could improve the glycemic control and result in a good prognosis in patients with diabetes.

  1. World Health Organization (WHO) (2006) Diabetes mellitus fact sheet no. 312. Geneva.
  2. Mehuys E, De Bolle L, Van Bortel L, Annemans L, Van Tongelen I, Remon JP, et al. Medication use and disease management of type 2 diabetes in Belgium. Pharm World Sci 2008; 30: 51?56.
  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047?1053
  4. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. 2010; 87: 4?14.
  5. Hamadeh RR. Noncommunicable diseases among the Bahraini population: a review. East Mediterr Health J 2000; 6: 1091?1097.
  6. Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet Med2002; 19: 954?957.
  7. Cheng YJ, Imperatore G, Geiss LS, Wang J, Saydah SH, Cowie CC, et al. Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988?2010. Diabetes Care 2013;36:2690?2696.
  8. Mansour M. Al-Nozha, Mohammed A. Al-Maatouq, Yaqoub Y. Al-Mazrou, Saad S. Al-Harthi, FACHARZT, Mohammed R. Arafah, FACC, Mohamed
  9. Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, Yachi Y, et al. Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: a meta-analysis. Am J Epidemiol 2012;176: 959?969.
  10. Warsy AS, El-Hazmi MA. Diabetes mellitus, hypertension and obesity-Common multi-factorial disorders in Saudis. East Mediterr Health J 1999; 5: 1236?1242.
  11. al-Nuaim AR, al-Rubeaan K, al-Mazrou Y, al-Attas O, al-Daghari N, Khoja T. High prevalence of overweight and obesity in Saudi Arabia. Int J Obes Relat Metab Disord 1996; 20: 547?552.
  12. al-Nuaim AA, Bamgboye EA, al-Rubeaan KA, al-Mazrou Y. Overweight and obesity in Saudi Arabian adult population, role of socio-demographic variables. J Community Health 1997; 22: 211?223.
  13. Carnethon MR, De Chavez PJ, Biggs ML, Lewis CE, Pankow JS, Bertoni AG, et al. Association of weight status with mortality in adults with incident diabetes. JAMA 2012; 308: 581?590.
  14. Alhyas L, McKay A, Balasanthiran A, Majeed A. Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic review. JRSM Short Rep 2011; 2: 55.
  15. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes ? causes, effects and coping strategies. Diabetes Obes Metab 2007; 9: 799?812.
  16. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome ? a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469?480.
  17. Khandekar S, Noeman SA, Muralidhar K, Gadallah M, Al-Sawaf KS. Central adiposity and atherogenic lipids in Saudi diabetics. Ann Saudi Med 1994;14:329?332.
  18. Musaiger A, Qashqari K. The relation between dressing and obesity among women in Saudi Arabia. Arab J Food Nutr 2005; 6: 292?302.
  19. al-Mahroos F, al-Roomi K. Overweight and obesity in the Arabian Peninsula: an overview. J R Soc Promot Health 1999; 119: 251?253.
  20. Amin TT, Al-Sultan AI, Ali A. Overweight and obesity and their association with dietary habits, and sociodemographic characteristics among male primary school children in Al-Hassa, Kingdom of Saudi Arabia. Indian J Community Med 2008; 33: 172?181.
  21. Busch CP, Hegele RA. Genetic determinants of type 2 diabetes mellitus. Clin Genet 2001; 60: 243?254.
  22. Dugoujon JM, Guitard E, S?n?gas MT, Roth MP, Sanchez A, Barny S, et al. Genetic markers of immunoglobulins and diabetes mellitus in the multiracial population of New Caledonia. The CALDIA Study Group. Diabetes Res Clin Pract 2000; 47: 209-215.
  23. Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM. Insulin Resistance and Risk of Incident Cardiovascular Events in Adults without Diabetes: Meta-Analysis. PLoS One 2012; 7: e52036.
  24. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, et al. Adiposity and mortality in type 1 diabetes. Int J Obes (Lond) 2009; 33: 796?805.
  25. van Vliet M, van der Heyden JC, Diamant M, von Rosenstiel IA, Schindhelm RK, Aanstoot HJ, et al. Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr 2010; 156: 923?929.
  26. Alhyas L, McKay A, Balasanthiran A, Majeed A. Quality of type 2 diabetes management in the states of the Co-operation Council for the Arab States of the Gulf: a systematic review. PLoS One 2011; 6: e22186.

[Ammar Balkheyour, Omar Ashour, Shahad AbuAlhamael, Shima Aziz and Hassan Alsini. (2017); BODY MASS INDEX ACCORDING TO INSULIN AND ORAL HYPOGLYCEMIC DRUG USAGE IN PATIENTS WITH TYPE 2 DIABETES. Int. J. of Adv. Res. 5 (May). 1140-1145] (ISSN 2320-5407). www.journalijar.com

Ammar Balkheyour
Teaching assistant and Senior Registrar in internal medicine, King Abdulaziz University

DOI:

Article DOI: 10.21474/IJAR01/4224      
DOI URL: https://dx.doi.org/10.21474/IJAR01/4224

Download Full Paper

Download PDF No. of Downloads: 39 | No. of Views: 295